Author Gelonch Capell, Paula |
Abstract The monoclonal antibodies products in the market have revolutionized the research and medical field, and currently it represents the half biopharmaceutical market products approximately. It is a market that is growing due to persistent innovation in the new drugs development and it is expected to continue doing so. The monoclonal antibodies production on a commercial scale is generally aimed at the diagnosis, therapy and new therapeutic agents research and development. Thus, this competitive industry is very strict with the cost, response time and regulatory requirements of the products. And now, the challenge is to develop and scale up purification processes capable of producing large quantities of purified monoclonal antibodies at the lowest possible cost. Key words: Immunoglobulins, monoclonal antibodies, hybridoma, culture medium, upstream, downstream, cell growth kinetics, buffer, sodium bicarbonate, purification. |
|
Director Lecina Veciana, Martí |
||
Degree IQS SE - Undergraduate Program in Biotechnology |
||
Date 2020-02-20
|